Clorox (CLX) EBT (2009 - 2026)

Clorox's EBT history runs 18 years deep, the most recent figure standing at $256.0 million for Q1 2026.

• On a quarterly basis, EBT rose 0.79% year-over-year to $256.0 million in Q1 2026; TTM through Mar 2026 was $988.0 million, a 4.77% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 170.85% from the prior year.
• EBT climbed to $256.0 million in Q1 2026 per CLX's latest filing, from $215.0 million in the prior quarter.
• Across five years, EBT topped out at $410.0 million in Q2 2025 and bottomed at -$245.0 million in Q1 2023.
• The 5-year median for EBT is $177.0 million (2024), against an average of $154.2 million.
• Across the five-year window, EBT slumped 222.5% in 2023 and soared 704.76% in 2025, its largest moves.
• Year by year, EBT stood at $130.0 million in 2022, then increased by 4.62% to $136.0 million in 2023, then soared by 74.26% to $237.0 million in 2024, then slipped by 9.28% to $215.0 million in 2025, then climbed by 19.07% to $256.0 million in 2026.
• Per Business Quant, the three latest CLX EBT figures stand at $256.0 million (Q1 2026), $215.0 million (Q4 2025), and $107.0 million (Q3 2025).